REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sitno Pharma S. R. O. (Slovakia)

Main Activities: Management Consulting Services | Administrative Management and General Management Consulting Services
Full name: Sitno Pharma S. R. O. Profile Updated: July 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sitno Pharma S. R. O. is based in Slovakia. The head office is in Bratislava. The enterprise operates in the Management Consulting Services industry. It was first established on November 15, 2012. 5 - 9 (2025) employees currently work for Sitno Pharma S. R. O.. The latest financial highlights indicate a net sales revenue drop of 20.3% in 2024. Its’ total assets recorded a negative growth of 1.78%. The net profit margin of Sitno Pharma S. R. O. decreased by 2.18% in 2024.

Headquarters
Rybne namestie, 1
Bratislava; Bratislavsky; Postal Code: 81102

Contact Details: Purchase the Sitno Pharma S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Sitno Pharma S. R. O. report to view the information.
Registered Capital:
Purchase the Sitno Pharma S. R. O. report to view the information.
Financial Auditors:
Purchase the Sitno Pharma S. R. O. report to view the information.
Incorporation Date:
November 15, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
25%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Sitno Pharma S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-20.3%▼
Total operating revenue
-30.74%▼
Operating profit (EBIT)
-37.57%▼
EBITDA
-28.69%▼
Net Profit (Loss) for the Period
-50.47%▼
Total assets
-1.78%▼
Total equity
0.77%▲
Operating Profit Margin (ROS)
-1.31%▼
Net Profit Margin
-2.18%▼
Return on Equity (ROE)
-0.8%▼
Debt to Equity Ratio
0.01%▲
Quick Ratio
0.07%▲
Cash Ratio
0.09%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo